Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods - The Australian Red Cross Blood Service: Blood Donor Centre Tamworth

Overview

The Therapeutic Goods Act 1989 was enacted by the Australian Parliament to regulate the provision and distribution of therapeutic goods within Australia. This Act was introduced to address the need for a robust framework to ensure the safety, quality, and efficacy of therapeutic goods available to the public. One of the key responsibilities of the Act is to manage the licensing of entities that manufacture these goods. The policy objective behind the Act is to protect public health by ensuring that therapeutic goods meet stringent standards before they enter the market. The recent revocation of a licence to manufacture therapeutic goods by the Secretary under this Act, as evidenced by the publication in the Gazette on 18 December 2012, underscores the Act's role in maintaining these standards by removing from the market those who no longer meet the required criteria, thereby safeguarding public health.

Scope and Application

The Therapeutic Goods Act 1989 applies to entities involved in the manufacture, supply, importation, and advertising of therapeutic goods in Australia. This encompasses a broad range of entities including companies, corporations, and individuals who engage in activities related to therapeutic goods, which are defined as products that are intended to diagnose, treat, mitigate, or prevent a disease, disorder, or abnormal physical state. The Act has national jurisdictional reach, covering all states and territories of Australia, as it is a Commonwealth Act. The revocation of a manufacturer's licence, as outlined in the document, is a specific instance of the Act's application. In this case, the licence of the Australian Red Cross Blood Service, an operating division of the Australian Red Cross Society, was revoked under paragraph 41(1)(d) at the request of the manufacturer. The Act may also extend or restrict its application through subordinate instruments, such as regulations or guidelines, which provide further detail on compliance and enforcement mechanisms. However, this document specifically addresses the revocation of a licence and does not elaborate on these subordinate instruments.

Key Provisions

The Therapeutic Goods Act 1989 provides various provisions regarding the regulation of therapeutic goods in Australia. Section 41(1)(d) of the Act allows the Secretary to revoke a licence to manufacture therapeutic goods under certain circumstances, such as when the manufacturer requests the revocation. This is the section under which the licence of the Australian Red Cross Blood Service, an operating division of the Australian Red Cross Society, has been revoked (section 41(1)(d)). This revocation is evidenced in the notice published by Bill Turner, the delegate of the Secretary, dated 18 December 2012. This notice indicates that the specific licence number MI-17082005-LI-000808-1, held by the Blood Donor Centre in Tamworth, NSW, has been revoked at the request of the manufacturer. The Act imposes several obligations and requirements on parties and entities that it governs. For manufacturers of therapeutic goods, the primary obligation is to maintain a valid licence to manufacture and distribute these goods. This licence must comply with all relevant regulations and standards set forth by the Therapeutic Goods Administration. Additionally, the manufacturer must ensure that their products meet safety and efficacy standards, and they must report any adverse events associated with their products. The revocation of a licence under section 41(1)(d) signifies that the manufacturer is no longer authorised to produce therapeutic goods, which impacts their ability to operate within the scope of the Act. Breaches of the Therapeutic Goods Act 1989 can lead to various civil and criminal consequences. Offences under the Act may include the manufacture, supply, or distribution of therapeutic goods without the required licence. Such offences can result in significant penalties, both civil and criminal, depending on the severity and intent of the breach. For example, the Act provides for fines and imprisonment for serious violations. While the specific penalties are not detailed in this notice, the potential consequences for operating without a valid licence can be severe, including substantial fines and imprisonment terms as stipulated in the Act. It is crucial for manufacturers to adhere to the regulatory requirements to avoid these penalties.